Form 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: July 24, 2002
(Date of Earliest Event Reported)
AMGEN INC.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware |
|
Commission File: |
|
95-3540776 |
| (State or Other Jurisdiction of
Incorporation or Organization) |
|
000-12477
|
|
(I.R.S. Employer Identification No.) |
| One Amgen Center Drive Thousand Oaks, California (Address of
Principal Executive Offices) |
|
|
|
91320-1799 (Zip
Code) |
(805) 447-1000
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. Other Events.
On July 24, 2002, Amgen Inc. issued a press release announcing its earnings for the quarter ended June 30, 2002. The press release is attached to this current report as Exhibit 99.1, and is
incorporated herein by reference.
ITEM 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press release by Amgen Inc. dated July 24, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
| AMGEN INC. |
| |
| By: |
|
/s/ RICHARD D. NANULA
|
| |
|
Name: Richard D. Nanula |
| |
|
Title: Executive Vice President, Finance,
Strategy and Communications, and Chief Financial Officer |
Date: July 25, 2002